Breast Cancer Breakthrough

 

Keeping up-to-date with the latest news on Breast Cancer is very beneficial.  Since this disease affects a large number of women, it is imperative that we take the necessary precautions.

Deprivation Could Be Linked To Breast Cancer Deaths

Breast Cancer Breakthrough“According to new research, funded by Cancer Research UK, deprivation could be responsible for around 450 deaths from breast cancer every year in England. Women in lower income groups are likely to be diagnosed when the disease is more advanced and treatment is less effective.

Eluned Hughes, Head of Public Health at Breakthrough Breast Cancer, said: “By focusing on improving early diagnosis, particularly in deprived areas, we can have most impact in stopping women dying from breast cancer. Around 1,000 women are still dying from breast cancer each month in the UK and we must continue our efforts to beat the disease – breast cancer is not yesterday’s problem.”

Read More.

LSUHSC Research Finds Combo Of Plant Nutrients Kills Breast Cancer Cells

Breast Cancer Breakthrough“A study led by Madhwa Raj, PhD, Research Professor in Obstetrics and Gynecology at LSU Health Sciences Center New Orleans and its Stanley S. Scott Cancer Center, has found that a super cocktail of six natural compounds in vegetables, fruits, spices and plant roots killed 100% of sample breast cancer cells without toxic side effects on normal cells. The results, which also revealed potential treatment target genes, are published in the November 2013 issue of The Journal of Cancer.

“One of the primary causes of both the recurrence of breast cancer and deaths is a small group of cancer stem cells that evade therapy,” notes Dr. Raj. “These often multi-drug-resistant cells have the ability to generate new tumors, so it is critically important to develop new approaches to more effective and safer treatment or prevention of breast cancer.”

Read More.

Novartis chases Pfizer in Hot New Breast Cancer Drug Area

Breast Cancer Breakthrough“Novartis is hot on the heels of Pfizer in developing a promising new type of breast cancer drug that analysts believe could generate billions of dollars in annual sales.

The Swiss drugmaker, which has previously kept its research programme under wraps, revealed on Friday that its experimental pill LEE011 was set to enter final-stage Phase III clinical trials next month.”

Read More.

 
 
 

New research, news and studies can help us in the disease prevention. For those who are already suffering this health problem, it is vital to be well informed.

Dr. Chris Charlton

Dr. Chris Charlton

Dr. Chris was born in Europe but has lived in the US for many years. He attended college both in Europe and the US and completed medical school at the University of Texas. Residency and fellowship in oncology was completed at Baylor. Read More...
Dr. Chris Charlton

Dr. Chris Charlton

Dr. Chris Charlton

Dr. Chris Charlton

Dr. Chris Charlton

Dr. Chris Charlton

Dr. Chris Charlton

Dr. Chris Charlton